Table 1.
Clinical and biochemical characteristics of the study subjects
| Non-CAD(n = 75) | CAD(n = 136) | P | |
|---|---|---|---|
| Age(years) |
55.05 ± 9.47 |
58.82 ± 10.54 |
0.011 |
| Males% (n) |
57(43) |
65(88) |
0.291 |
| Current smokers%(n) |
31(23) |
46(74) |
0.027 |
| Hypertension%(n) |
68(51) |
78(106) |
0.113 |
| Diabetes%(n) |
33(25) |
37(50) |
0.618 |
| BMI(kg/m2) |
27.43 ± 2.20 |
27.24 ± 2.57 |
0.580 |
| Systolic BP(mmHg) |
141.11 ± 17.05 |
141.79 ± 19.05 |
0.801 |
| Diastolic BP(mmHg) |
82.08 ± 13.33 |
81.161 ± 14.29 |
0.648 |
| HR(bpm) |
74.67 ± 12.66 |
72.82 ± 11.69 |
0.289 |
| FPG(mmol/L) |
5.97 ± 1.34 |
6.53 ± 1.58 |
0.011 |
| TC(mmol/L) |
4.86 ± 1.12 |
5.02 ± 1.14 |
0.341 |
| TG(mmol/L) |
1.92(1.58-2.18) |
2.09(1.48-2.57) |
0.197 |
| LDL-c(mmol/L) |
2.82 ± 0.85 |
2.89 ± 0.93 |
0.549 |
| HDL-c(mmol/L) |
1.06(0.93-1.23) |
1.06(0.91-1.21) |
0.541 |
| SCr(mmol/L) |
70.73 ± 16.74 |
70.56 ± 13.59 |
0.938 |
| CG-eGFR(ml/min/1.73 m2) |
112.04 ± 27.60 |
104.92 ± 26.04 |
0.064 |
| UA(μmol/L) |
319.00 ± 82.47 |
331.56 ± 94.53 |
0.335 |
| Fibrinogen(g/L) |
3.30 ± 0.68 |
3.58 ± 0.78 |
0.012 |
| Cystatin C(mg/L) |
0.86 ± 0.16 |
0.93 ± 0.18 |
0.004 |
| Gensini score | 8.00(2.5-12.00) | 42.0(27–53.75) | <0.001 |
BMI, body mass index; BP, blood pressure; HR, heart rate; FPG, fasting plasma glucose; TC, total cholesterol; TG, triglyceride; LDL-c, low-density lipoprotein cholesterol; HDL-c, high-density lipoprotein cholesterol; SCr, serum creatinine; UA, uric acid. Data are means ± SD or median (interquartile range).